Day: April 2, 2021

RESEARCH TRIANGLE PARK, N.C., April 02, 2021 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the grant of inducement stock options exercisable for an aggregate of 46,300 shares of G1’s common stock to eight employees under the G1 Therapeutics, Inc. 2021 Inducement Equity Incentive Plan (the “Inducement Plan”). The stock options were granted as an inducement material to the new employee’s becoming an employee of G1 in accordance with Nasdaq Listing Rule 5635(c)(4). The Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of G1 (or following a bona fide period of non-employment), as an inducement material to such individual’s entering into employment with G1, pursuant to Rule 5635(c)(4) of the Nasdaq Listing...

CALGARY, Alberta, April 02, 2021 (GLOBE NEWSWIRE) — Jura Energy Corporation (“Jura” or the “Company”) announces today the grant of restricted share units (“RSUs”) under the Company’s amended and restated restricted share unit plan (the “RSU Plan”) which was approved by shareholders on May 31, 2019. Jura granted an aggregate of 328,762 RSUs to certain of its non-executive directors in settlement of a portion of their directors’ compensation for the quarters ended June 30, 2020, September 30, 2020, December 31, 2020 and March 31, 2021. The RSUs vest as to one third on each of the first, second and third anniversaries of their date of grant. Each RSU entitles the holder to acquire one common share of the Company by delivering an exercise notice in accordance with the RSU Plan. The Company has granted an aggregate of 1,550,515 RSUs...

DUBLIN, Ireland, April 02, 2021 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that it has granted non-statutory stock options to purchase an aggregate of 106,000 ordinary shares of Nabriva Therapeutics as an inducement to two newly-hired employees. These grants included a non-statutory option to purchase 100,000 ordinary shares of Nabriva Therapeutics awarded to Daniel Dolan, Nabriva’s newly appointed Chief Financial Officer. Both awards were made pursuant to the Nasdaq inducement grant exception as a component of the new hires’ employment compensation. The stock options were granted effective March 31, 2021 with an exercise price of $1.66 per share, which is...

SAN FRANCISCO, April 02, 2021 (GLOBE NEWSWIRE) — Kalytera Therapeutics, Inc. (TSX VENTURE EXCHANGE: KLY and OTC: KALTF) (the “Company” or “Kalytera“) today announced that the Company has changed its name to Claritas Pharmaceuticals, Inc. The decision to rename the Company signals the re-launch of the Company, and its intent to focus on the development of its proprietary drug, R-107, for the treatment of vaccine-resistant strains of COVID-19 as well as other viral infections. R-107 is a nitric oxide-releasing molecule designed to treat vaccine-resistant COVID-19 infection as well as the viruses that cause influenza and the common cold. The Company’s ticker symbol will change as a result of the name change. The new ticker symbol will be CLAS, pending final approval of the TSX Venture Exchange which is anticipated...

STAMFORD, Conn., April 02, 2021 (GLOBE NEWSWIRE) — Patriot National Bancorp, Inc. (“Patriot,” “Bancorp” or the “Company”) (NASDAQ: PNBK), the parent company of Patriot Bank, N.A. (the “Bank”), today announced a net loss of $1.4 million, or $0.35 basic and diluted loss per share for the quarter ended December 31, 2020, compared to a net loss of $87 thousand reported in the third quarter of 2020. The net loss for the year ended December 31, 2020 was $3.8 million, or $0.97 per fully diluted share, as compared to a net loss of $2.8 million, or $0.72 per fully diluted shares in the fiscal year 2019. The Bank’s loan loss provision on a year over year basis is down $2.8 million, or 56.3% to $2.2 million for the twelve months ended December 31, 2020. During the fourth quarter, Patriot recorded a $1.9 million charge associated with the establishment...

Appointment of Anthony Horton as Executive Chair TORONTO, April 02, 2021 (GLOBE NEWSWIRE) — Just Energy Group Inc. (“Just Energy” or the “Company”) (OTC: JENGQ), a retail energy provider specializing in electricity and natural gas commodities and bringing energy efficient solutions and renewable energy options to customers, announced today that the order under the Companies’ Creditors Arrangement Act (Canada) (“CCAA”) issued on March 19, 2021 has been given full force and effect in the United States under Chapter 15 of Title 11 of the U.S. Code in the cases currently pending in the Bankruptcy Court for the Southern District of Texas.   The Company also announced that the current Chairman of the Board, Anthony Horton, has been appointed as Executive Chair of the Company by the Board to, among other things, oversee and provide strategic...

LES HOTELS BAVEREZ S.A. 2, place des Pyramides 75001 PARISCapital € 10.127.050 – Code NAF 5510 ZR.C.S. PARIS 572 158 558 ISIN : FR 0007080254Mnémonique : ALLHBEURONEXT Growth Nombres d’actions et de droits de vote au 31/03/2021 Au 31 mars 2021, le nombre total d’actions composant le capital social de la société s’élève à 2 372 468. Le nombre total de droits de vote à la même date est de 3 864 268. Pièces jointesDeclaration_AMF-DDV_au_31_03_21 Declaration_AMF-DDV_au_31_03_21

Nanterre, le 2 avril 2021 Déclaration des transactions sur actions propres Période du 29 mars 2021 au 02 avril 2021(article 241-4, I Règlement Général de l’Autorité des Marchés Financiers et position-recommandation de l’Autorité des Marchés Financiers DOC-2017-04) Présentation agrégée par jour et par marchéNom de l’émetteur Code identifiant de l’émetteur (code LEI) Jour de la transaction Code identifiant de l’instrument financier Volume total journalier (en nombre de titres) Prix pondéré moyen journalier d’acquisition Code identifiant marchéFAURECIA 969500F0VMZLK2IULV85 29/03/2021 FR0000121147 166 294 43,8414 XPARFAURECIA 969500F0VMZLK2IULV85 29/03/2021 FR0000121147 117 508 43,8825 CEUXFAURECIA 969500F0VMZLK2IULV85 29/03/2021 FR0000121147 32 041 43,8863 TQEXFAURECIA 969500F0VMZLK2IULV85 30/03/2021 FR0000121147 25...

NEW YORK, April 02, 2021 (GLOBE NEWSWIRE) — Apollo Strategic Growth Capital II (the “Company”) announced that commencing April 5, 2021, holders of the units sold in the Company’s initial public offering (including units sold to the underwriters pursuant to their partial exercise of the over-allotment option) may elect to separately trade the Class A ordinary shares and warrants included in the units. Class A ordinary shares and warrants that are separated will trade on the New York Stock Exchange under the symbols “APGB” and “APGB WS,” respectively. Those units not separated will continue to trade on the New York Stock Exchange under the symbol “APGB.U”. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. This press release shall not constitute an offer to sell or the solicitation...

Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de Commerce et l’article 223-16 du règlement général de l’Autorité des marchés financiers (AMF) Situation au 31 mars 2021Nombre de titres composant le capital en circulation 59 322 908Nombre de titres bénéficiant du vote double 2 702 842Nombre total de droits de vote bruts 62 025 750Nombre de titres privés du droit de vote -549 066Nombre total de droits de vote exerçables 61 476 684Place de cotation : Euronext Paris Lieu d’échange : Eurolist A d’Euronext Paris (SRD)Code valeur : ILD Code ISIN : FR0004035913Classification FTSE : 974 Internet Membre du Euro Stoxx, SBF 120, CAC Mid 100Ce document est accessible en PDF sur le site de la Société,dans la rubrique Information réglementée www.iliad.fr Pièce...